Department of Ophthalmology, Keio University School of Medicine, Shinjuku-ku, Tokyo, Japan.
Department of Clinical Regenerative Medicine, Fujita Medical Innovation Center, Fujita Health University, Ota-ku, Tokyo, Japan.
Medicine (Baltimore). 2024 Sep 27;103(39):e39767. doi: 10.1097/MD.0000000000039767.
Patients with atopic dermatitis undergoing penetrating keratoplasty (PKP) face a high risk of postoperative complications. Endothelial keratoplasty may be a safer alternative for such patients, including those with abnormal anterior chamber anatomy.
3 male patients, aged 33 to 44, presented with blurred vision at Keio University Hospital.
Bullous keratopathy was diagnosed through slit-lamp examination and specular microscopy. Two patients had well-controlled systemic atopic dermatitis, while 1 had blepharitis associated with atopic dermatitis. Two patients had peripheral anterior synechia, and 2 had undergone glaucoma surgery before keratoplasty.
Non-Descemet stripping endothelial keratoplasty (nDSAEK) was performed by a single surgeon.
The best-corrected visual acuity ranged from 0.7 to 1.5 logMAR before surgery and from 0.2 to 2.3 logMAR after surgery. One year post-surgery, the graft remained clear in 2 cases; however, in the case of repeated glaucoma surgeries after nDSAEK, the graft became edematous. Corneal endothelial cell density was 1586 and 1988 cells/mm² in 2 cases and undetectable in the failed case. The follow-up period ranged from 2.5 to 9 years.
Despite the presence of peripheral anterior synechia or prior glaucoma surgery, some patients experienced a favorable long-term postoperative course following nDSAEK. This procedure may offer a safer alternative for treating patients with atopic dermatitis who have ocular complications that present a high risk for PKP.
患有特应性皮炎的患者行穿透性角膜移植术(PKP)后,面临较高的术后并发症风险。对于此类患者,包括那些眼前节解剖异常的患者,内皮角膜移植术可能是一种更安全的选择。
3 名男性患者,年龄 33 至 44 岁,在庆应义塾大学医院就诊时出现视力模糊。
通过裂隙灯检查和共焦显微镜诊断为大泡性角膜病变。2 例患者的系统性特应性皮炎得到良好控制,1 例患者合并特应性皮炎的睑缘炎。2 例患者有周边前粘连,2 例患者在角膜移植术前曾行青光眼手术。
由同一位外科医生行非撕除式内皮角膜移植术(nDSAEK)。
术前最佳矫正视力为 0.7 至 1.5 logMAR,术后为 0.2 至 2.3 logMAR。术后 1 年,2 例患者的移植物仍保持透明;然而,在 nDSAEK 后行多次青光眼手术后,移植物出现水肿。2 例患者的角膜内皮细胞密度为 1586 和 1988 个细胞/mm²,1 例失访患者的角膜内皮细胞密度无法检测。随访时间为 2.5 至 9 年。
尽管存在周边前粘连或既往青光眼手术史,一些患者在 nDSAEK 后仍获得了良好的长期术后效果。对于患有特应性皮炎且存在 PKP 高风险眼部并发症的患者,该手术可能是一种更安全的选择。